On the other hand, some studies have demonstrated that DCs can induce the production of Th2, CD4+CD25+Foxp3+ regulatory T cells (Tregs), thus exerting a certain degree of immunosuppressive effect (81, 82), which can inhibit the progression of IBD. The gene discussed is CD4; the disease is inflammatory bowel disease.